Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 6/9/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. John Didsbury

Wrong Dr. John Didsbury?

President and Chief Executive Off...

Local Address: North Carolina, United States
T3D Therapeutics , Inc.
 
Background

Employment History

Education

  • Ph.D.
  • PhD
  • Ph.D. , Medical Microbiology
    University of Vermont Medical College
  • Bachelor of Arts , biology/chemistry
    University of Connecticut
87 Total References
Web References
Executive Management Team | T3D Therapeutics
www.t3dtherapeutics.com, 9 June 2014 [cached]
John Didsbury, Ph.D. President & CEO, Chairman of the Board Dr. Didsbury is a seasoned Executive Manager with over 24 years of experience within the pharmaceutical and biotechnology industries in both small and large public and private companies. Dr. Didsbury was President/COO/CSO of DARA BioSciences, Inc. (NASDAQ:CM - DARA). At DARA he led the development of T3D-959 and directed all operations of the business, overseeing all finances, financing efforts, business development, human resources and administration and directing all drug discovery programs of the company in a CSO role. He played a key role in taking the company public in 2008 through a reverse merger. Dr. Didsbury served as CEO of Nuada Pharmaceuticals Inc. Prior to his tenure at Nuada Dr. Didsbury was Head of Strategy and Operations at GlaxoSmithKline, Inc. Previously, Dr. Didsbury served as Associate Director of Biology at Macronex, Inc., as Assistant Professor of Medicine at Duke University Medical Center and as a scientist at Genentech, Inc.
John Didsbury is CEO of ...
www.heraldsun.com, 24 April 2014 [cached]
John Didsbury is CEO of T3D Therapeutics, a startup company that is seeking money to carry a diabetes candidate into studies as a treatment for Alzheimer's disease.
DURHAM -
A Research Triangle Park drug development startup company is looking to raise money to further studies of a drug candidate that was originally targeted as a treatment for diabetes as a treatment for Alzheimer's disease. T3D Therapeutics CEO Dr. John Didsbury said the start-up company licensed a diabetes drug candidate from Dara BioSciences, a Raleigh-based pharmaceutical company focused on cancer supportive care products and on developing cancer treatments.
...
Didsbury was formerly chief scientific officer at Dara. "It's been a personal mission of mine to identify and develop a breakthrough medicine for any disease, and this particular drug is the culmination of the search," Didsbury said of the drug candidate, which he said he believes could have multiple mechanisms for treating Alzheimer's. "It's a tough haul, but one that just requires perseverance and tenacity." Didsbury said there are "striking similarities" between diabetes and Alzheimer's. The company's drug candidate would work in multiple ways by regulating enzymes involved in Alzheimer's defects, he said. "It acts in a myriad of ways, and like I said, it regulates the levels of certain key enzymes that are involved in the pathophysiology of the disease," he said.
...
Through T3D Therapeutics, Didsbury is looking to raise money to try to carry the diabetes drug that his company licensed from Dara into Phase 2 trials.
...
Didsbury said the additional funding will allow the company to do some pre-clinical work, but they're still evaluating their financial strategy to figure out a way to pay for Phase 2 trials. He said company has applied for grants from the National Institutes of Health and other organizations.
medicaldevicelicensing.com: Industry news
medicaldevicelicensing.com, 18 Feb 2013 [cached]
RALEIGH, North Carolina, March 25 /PRNewswire/ -- DARA BioSciences(TM) (Nasdaq: DARA) announced today the appointment of John Didsbury, Ph.D. as President and Chief Operating Officer. Dr.... http://medicaldevicelicensing.com/redirs/news_rss/news/viewNewsML/611 http://medicaldevicelicensing.com/redirs/news_rss/news/viewNewsML/611
ILG Team
www.ilgcap.net, 30 Mar 2014 [cached]
John Didsbury, Ph.D. President/Chief Executive Officer Nuada Pharmaceuticals Inc.
...
Dr. Didsbury has over 18 years of executive management experience within pharmaceutical and biotechnology industries. He took three drug discovery programs to selection of clinical candidate molecules within 14 months by raising $10 Million. Dr. Didsbury has been associated the following companies: Nuada Pharmaceuticals (CEO), GlaxoSmithKline, Macronex, Genentech and Duke University Medical Center. He earned his B.A. in Biology/Chemistry at University of Connecticut in 1977, and his Ph.D. in Medical Microbiology at University of Vermont Medical College in 1982.
John Didsbury, Ph.D. (View ...
www.ddcoi.org, 19 April 2011 [cached]
John Didsbury, Ph.D. (View Profile) President and CEO, DDCOI
Other People with the name "Didsbury":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.